Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1694413rdf:typepubmed:Citationlld:pubmed
pubmed-article:1694413lifeskim:mentionsumls-concept:C0010674lld:lifeskim
pubmed-article:1694413lifeskim:mentionsumls-concept:C0226928lld:lifeskim
pubmed-article:1694413lifeskim:mentionsumls-concept:C0028631lld:lifeskim
pubmed-article:1694413lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:1694413lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:1694413lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:1694413lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:1694413lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:1694413pubmed:issue6 Pt 2lld:pubmed
pubmed-article:1694413pubmed:dateCreated1990-8-2lld:pubmed
pubmed-article:1694413pubmed:abstractTextAdenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP) levels were measured in labial gland slices from controls and patients with cystic fibrosis (CF). Incubation in vitro with 10 microM epinephrine, 50 microM isoproterenol, or 10 microM carbachol increased cAMP levels by 2.3-fold, 3.1-fold, and 1.8-fold, respectively, in control glands and by similar amounts in CF glands. The only statistically significant CF-related difference was a decreased response to isoproterenol. Addition of MIX (3-isobutyl-1-methylxanthine) increased cAMP levels in control and CF glands by an order of magnitude under all conditions but did not eliminate the CF-related decrease in cAMP level obtained with isoproterenol. cGMP levels were measured only in the presence of MIX. Incubation with carbachol nearly doubled cGMP levels in control and CF glands but only the control gland response approached statistical significance (P = 0.06). cGMP levels in CF glands were nearly threefold greater than those in control glands, and disease-related differences obtained in the presence of carbachol and isoproterenol were statistically significant.lld:pubmed
pubmed-article:1694413pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1694413pubmed:languageenglld:pubmed
pubmed-article:1694413pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1694413pubmed:citationSubsetIMlld:pubmed
pubmed-article:1694413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1694413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1694413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1694413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1694413pubmed:statusMEDLINElld:pubmed
pubmed-article:1694413pubmed:monthJunlld:pubmed
pubmed-article:1694413pubmed:issn0002-9513lld:pubmed
pubmed-article:1694413pubmed:authorpubmed-author:IzutsuK TKTlld:pubmed
pubmed-article:1694413pubmed:authorpubmed-author:AllanB JBJlld:pubmed
pubmed-article:1694413pubmed:authorpubmed-author:TrueloveE LELlld:pubmed
pubmed-article:1694413pubmed:authorpubmed-author:RamseyB WBWlld:pubmed
pubmed-article:1694413pubmed:authorpubmed-author:SchubertM MMMlld:pubmed
pubmed-article:1694413pubmed:authorpubmed-author:EnsignW YWYlld:pubmed
pubmed-article:1694413pubmed:issnTypePrintlld:pubmed
pubmed-article:1694413pubmed:volume258lld:pubmed
pubmed-article:1694413pubmed:ownerNLMlld:pubmed
pubmed-article:1694413pubmed:authorsCompleteYlld:pubmed
pubmed-article:1694413pubmed:paginationR1320-6lld:pubmed
pubmed-article:1694413pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:meshHeadingpubmed-meshheading:1694413-...lld:pubmed
pubmed-article:1694413pubmed:year1990lld:pubmed
pubmed-article:1694413pubmed:articleTitleCyclic nucleotide responses in control and cystic fibrosis labial glands.lld:pubmed
pubmed-article:1694413pubmed:affiliationDepartment of Oral Biology, School of Dentistry, University of Washington, Seattle 98195.lld:pubmed
pubmed-article:1694413pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1694413pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed